Lomitapide, relief pitcher for patients with homozygous familial hypercholesterolemia

被引：4
|
作者：
Kim, Sang-Hyun [1 ]
Baek, Sang Hong [2 ]
机构：
[1] Seoul Natl Univ, Seoul Boramae Hosp, Coll Med, Cardiol,Internal Med, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Internal Med, Cardiovasc Med, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2020年 / 27卷 / 02期
关键词：
EFFICACY;
D O I：
10.1177/2047487319881240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [1] Lomitapide for the Management of Homozygous Familial Hypercholesterolemia
    deGoma, Emil M.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 (02) : 109 - 118
  • [2] Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
    Harada-Shiba, Mariko
    Ikewaki, Katsunori
    Nohara, Atsushi
    Otsubo, Yoshihiko
    Yanagi, Koji
    Yoshida, Masayuki
    Chang, Qing
    Foulds, Pamela
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (04) : 402 - 411
  • [3] Lomitapide for use in patients with homozygous familial hypercholesterolemia: a narrative review
    Neef, Daniela
    Berthold, Heiner K.
    Gouni-Berthold, Ioanna
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (05) : 655 - 663
  • [4] Lomitapide: a novel drug for homozygous familial hypercholesterolemia
    Panno, Maria D.
    Cefalu, Angelo B.
    Averna, Maurizio R.
    CLINICAL LIPIDOLOGY, 2014, 9 (01) : 19 - 32
  • [5] MTP Gene Variants and Response to Lomitapide in Patients with Homozygous Familial Hypercholesterolemia
    Kolovou, Genovefa D.
    Kolovou, Vana
    Papadopoulou, Anna
    Watts, Gerald F.
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (07) : 878 - 883
  • [6] Lomitapide for treatment of homozygous familial hypercholesterolemia: The Quebec experience
    Aljenedil, Sumayah
    Alothman, Latifah
    Belanger, Alexandre M.
    Brown, Leslie
    Lahijanian, Zubin
    Bergeron, Jean
    Couture, Patrick
    Baass, Alexis
    Ruel, Isabelle
    Brisson, Diane
    Khoury, Etienne
    Gaudet, Daniel
    Genest, Jacques
    ATHEROSCLEROSIS, 2020, 310 : 54 - 63
  • [7] US FDA approves lomitapide for homozygous familial hypercholesterolemia
    Wilson, Hannah
    CLINICAL LIPIDOLOGY, 2013, 8 (01) : 11 - 12
  • [8] Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia
    Davis, Kyle A.
    Miyares, Marta A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (12) : 1001 - 1008
  • [9] Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide
    Giammanco, Antonina
    Cefalu, Angelo B.
    Noto, Davide
    Averna, Maurizio R.
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (23) : 3773 - 3783
  • [10] Lomitapide in homozygous familial hypercholesterolemia: our clinical experience
    Citta, D.
    Nota, F.
    Napoli, F.
    Frascaroli, C.
    Pisu, E.
    Massucco, P.
    Cavalot, F.
    Bonomo, K.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 131 - 131
12345